Smoking - An emerging risk factor for renal diseases

East African Medical Journal

Volumn 75, Issue 3, 1998, Pages 171-174

  McLigeyo, S O ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ARTICLE; DIABETIC NEPHROPATHY; HUMAN; KIDNEY DISEASE; PROTEINURIA; RISK FACTOR; SMOKING;

COST OF ILLNESS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RISK FACTORS; SMOKING;

EID: 0031809346     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Bartechi CE, Mackenzie, T.D. and Schrier, R.W. The human costs of tobacco use. First of two parts. N. Engl. J. Med. 1994; 330:907-912.
2. Jungle, B. jahrbuch sucht' 96: Tabak, in Hamm: Deutsche Haupstelle gegen diesuchtgefahren 1996, pp 69-83.
3. Holbrook, J.S, Grundy, S.M, Henekens, C.H, Kannel, W.B. and Strong, J.P. Cigarette smoking and cardiovascular disease: A statement for health professionals by a taskforce appointed by the steering committee of the American Heart Association. Circulation. 1984; 70: 1114A-1117A.
4. Parkin, D.M., Pisani, P., Lopez, A.D. and Masuyer, E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int. J. Cancer. 1994; 59: 494-504.
5. Sherman, C.B. The health consequences of cigarette smoking: Pulmonary diseases. Med. Clin. N. Am. 1992; 76: 355-375.
6. McLaughlin, J.K., Silverman, D.T., Hsing, A.W., Ross, R.K., Schoenberg, JB. and Yum, C. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res. 1992; 52: 254-257.
7. Schelehofer, B., Heuer, C, Blettner, M., Niehoff, D. and Wahrendorf, J. Occupation, smoking and demographic factors and renal cell carcinoma in Germany. Int. J. Epidemiol. 1995; 24: 51-57.
8. Pawlick, W.W., Jacobson, E.D. and Banks, R.O. Actions of nicotine on renal function in dogs. Proc. Soc. Exp. Biol. Med. 1985; 178: 585-590.
9. Ekberg, G., Grefberg, N., Larsson, L.O. and Vaara, I. cigarette smoking and glomerular filtration rate in insulin treated diabetics without manifest nephropathy. J. Intern. Med. 1990; 228: 211-217.
10. Hostetter, T.H. Progression of renal disease and renal hypertrophy. Annu. Rev. Physiol. 1995; 57: 263-278.
11. Bum, J.H., Truelove, L.H. and Burn, I. The antidiuretic action of nicotine and of smoke. Brit. Med. J. 1945; 1:403-406.
12. Rowe, J.W., Kilgore, A. and Robertson, G.L. Evidence in man that cigarette smoking induces vasopressin release via an airway-specific mechanism. J. Clin. Endocrinol. Metab. 1980; 51: 170-172.
13. Banker, L., Bouby, N. and Trinh-Trang-Tan M.M. Vasopressin-dependent kidney hypertrophy: Role of urinary concentration in protein induced hypertrophy and in the progression of chronic renal failure. Am. J. Kidney Dis. 1992; 17: 661-665.
14. Hultberg, B., Isaksson, A., Brattstrom, L. and Isralsson, B. Elevated urinary excretion of B-hexosaminidase in smokers. Eur. J. Clin. Biochem. 1992; 30: 131-133.
15. Hesse, E. Ein fluss des Rauchens auf den Kreislauf. Dtsh. Arch. Klin. Med. 1907; 295: 573-577.
16. Cryer, P.E., Haymond, MW., Santiago, J.V. and Shah, S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking associated hemodynamic and metabolic events. N. Engl. J. Med. 1976; 295: 573-577.
17. Groppelli, A., Giorgi, D.M.A., Omboni, S., Parati, G. and Manchia, G. Persistent blood pressure increase induced by heavy smoking. J. Hypertens. 1992; 10: 495-499.
18. Hansen, K.W., Pedersen, MM., Christiansen, J.S. and Mogensen, C.E. Night blood pressure and cigarette smoking association in healthy subjects and diabetic patients. Blood Pressure. 1994; 3: 381-388.
19. Barna, I., Kempler, P., Buki, B. and De Chatel, R. The influence of chronic smoking on the diurnal rhythm of blood pressure in healthy individuals and in insulin dependent diabetic patients (abstract). Nephrol. Dial. Transplant. 1996; 11: A80.
20. Klag, M.J., Whelton, P.K., Randall, B.L., Neaton, J.D., Bracati, F.L., Ford, C.E., Shulman, N.B. and Stamler, J. Blood pressure and end-stage renal disease in men. N. Engl. J. Med. 1996; 334: 13-18.
21. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F.E., Motolese, M., Ponticelli, C., Ritz, E. and Zucchelli, P. Angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group: Effect of the insufficiency angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal. N. Engl. J. Med. 1996; 334: 939-945.
22. Facchini, F.S., Hollenbeck, C.B., Jeppesen, J., Chen, Y-DI and Reven, GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-1130.
23. Eliasson, B., Atvall, S., Taskinen, M-R and Smith, U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler. Thromb. 1994; 14: 1946-1950.
24. Godsland, I.F., Wynn, V., Wolton, C. and Stevenson, J.C. Insulin resistance and cigarette smoking. Lancet. 1992; 339: 1619-1620.
25. Wang, P.H., Lau, J. and Chalmers, T.C. Meta-analysis of effects of intensive blood glucose control on late complications of type 1 diabetes. Lancet. 1993;341:1306-1309.
26. Hawkins, R.I. Smoking, platelets and thrombosis. Nature 1972; 236: 450-452.
27. Nadler, J.L., Velasco, J.S. and Horton, R. Cigarette smoking inhibits prostacyclin formation. Lancet. 1983; 4: 1248-1250.
28. Barrow, S.E., Ward, P.S., Sleightholm, M.A., Ritter, J.M. and Dollery, C.T. Cigarette smoking: Profiles of thromboxane and prostacyclin-derived products in human urine. Biochim. Biophys. Acta. 1989; 993: 121-127.
29. Uedelhofen, W.N., Rutzel, A., Meese, C.O. and Weber. P.C. Smoking alters thromboxane metabolism in man. Biochim. Biophys. Acta. 1991; 1081: 197-201.
30. Noronha-Dutra, A.A., Epperlen, M.M. and Woolf, N. Effects of cigarette smoking on cultured human endothelial cells. Cardiovsc. Res. 1993; 27: 774-778.
31. Celermajer, D.S., Adams, M.R., Clarkson, P., Robinson, J., McCredie, R., Donald, A. and Deanfield, J.E. Passive smoking and impaired endothelial-dependent arterial dilatation in healthy young adults. N. Engl. J. Med. 1996; 334: 150-154.
32. Sauty, A., Mauel, J., Philippealaux, M-M. and Leuenberger, P. Cytostatic activity of alveolar macrophages from smokers and non-smokers: Role of interleukin-1B, interleukin-6 and tumour necrosis factor-alpha. Cell. Mol. Biol. 1994; 11:631-637.
33. Hockertz, S., Emmendorffer, A., Scherer, G., Ruppert, T., Daube, H., Tricir, A.R. and Aderoller, F. Acute effects of smoking and high experimental exposure of environmental tobacco smoke (ETS) on the immune system. Cell. Biol. Toxicol. 1994; 10: 177-190.
34. Ritz, E., Nowiciki, M., Fliser, D., Horner, D. and Klimm, H.P. Proteinuria and hypertension. Kidney Int. 1994; 14: (suppl 47): S76-S80
35. Mimran, A., Ribstein, J., Ducailar, G. and Halimi, J.M. Albuminuria in normals and essential hypertension. J. Diabetes Compl. 1994; 8: 150-156.
36. Horner, D., Fliser, D., Klimm, H.P. and Ritz, E. Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J. Hypertens. 1996; 14: 655-660.
37. Derket, T., Feldt-Rasmussen, B., Borch-Johnson, K., Jensen, T. and Kofoad-Enavoldsen, A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia 1989; 32: 219-226.
38. Whelton, P.K., Randal, B., Neaton, J., Stamler, J., Bralcati, F.L. and Klag, M.J. Cigarette smoking and ESRD incidence in men screened for the MRFIT (abstract).J. Am. Soc. Nephrol. 1995; 408A
39. Muhlhauser, I., Sawicki, P., Berger, M. Cigarette smoking as a risk factor for macroproteinuria and proliferate retinopathy in type I (insulin-dependent) diabetes. Diabetologia 1986;29:500-502.
40. Couper, J.J., Staples, A.J., Coccioloner, R., Nairn, J.. Badcock, N. and Henning, P. Relationship of smoking and albuminuria in children with insulin dependent diabetes. Diabetic Med. 1994; 11: 666-669.
41. Almdal, T., Norgaard, K., Feldt-Rasmussen, B. and Deckert, T. The predictive value of microalbuminuria in IDDM. A five year follow-up study. Diabetes Care. 1994; 17: 120-125.
42. Chase, H.P., Garg, S.K., Marshall, G., Berg, C.L., Harris, S., Jackson, W.E. and Hamman, R.E. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. J. Amer. Med. Ass. 1991; 265: 614-617.
43. Microalbuminuria collaborative study group. United Kingdom: Risk factors for development of microalbuminuria in insulin dependent diabetic patients. A cohort study. Brit. Med. J. 1993;1235-1239.
44. Stegmayr B, Lithner F: Tobacco and end stage diabetic nephropathy.Br. Med. J. 1987; 295:581-582.
45. Perry, I. J., Wannamethee, S.G., Walker, M. K., Thomson, A.C., Whincup, P.H. and Shaper, A.G. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. Brit. Med. J. 1995; 310: 560-564.
46. Oliverius, N.D.E.F., Andreasen, A.H., Keiding, N. and Mogensen, C.E. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients.Cross-sectional data from the population-based study "Diabetes Care in General Practice," Denmark. Diabetologia. 1993; 36: 1007-1016.
47. Keller, C.K., Bergish, K.E.T., Fliser, D., Ritz, E. Renal findings in patients with short term type 2 diabetes. J. Am. Soc. Nephrol. (in press).
48. Bruno, G., Cavallo-Perin, P., Bargero, G., Borra, M., Calvi, V., D'Errico, N., Daembrogio, P. and Pagano, G. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population - based cohort of NTDM subjects. Diabetes Care. 1996; 19:43-47.
49. Sawicki, P.T., Didcrgeti, U., Muhlhauser, I., Bender, R., Heinemann, L. and Berger, M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care. 1994; 17: 126-131.
50. Chapman, A.B., Johnson, A.M., Gabow, P.A. and Schrier, R.W. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 1994; 5: 1349-1354.
51. Ward, M.M. and Studenski, S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch. Intern. Med. 1992; 152: 2082-2088.
52. Yaqoob, M., Bell, G.M., Percy, D.F. and Finn, R. Primary glomerulonephritis and hydrocarbon exposure: A case-control study and literature review. Q. J. Med. 1992; 83: 409-418.
53. Herody, M., Bobtrie, G., Gouarin, C., Grunfield, J.P., Noel, L.H. Anti-GBM disease: Predictive value of clinical histological and serologjcal data. Clin. Nephrol. 1993; 40: 249-255.
54. Appel, R.G., Bleyer, A.J., Revis, S., Hansen, K.J. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 1995; 48: 171-176.